Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0UF8E
|
|||
| Former ID |
DIB014397
|
|||
| Drug Name |
XOMA-629
|
|||
| Synonyms |
Acne therapy, XOMA; BPI peptides, XOMA; XMP-629; XMP.629; BPI peptide (acne, Staphylococcus infection, impetigo), Xoma; Bactericidal permeability increasing protein (acne, Staphylococcus infection, impetigo), XOMA
Click to Show/Hide
|
|||
| Indication | Acne vulgaris [ICD-11: ED80; ICD-10: L70.0; ICD-9: 706.1] | Phase 2 | [1] | |
| Company |
XOMA Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Protein bactericidal permeability-increasing (BPI) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of XOMA Ltd. | |||
| REF 2 | Modulating immunity as a therapy for bacterial infections. Nat Rev Microbiol. 2012 Mar 16;10(4):243-54. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.